Bayer Crop Science seeks approval for Ravi Kirpalani as independent director
- Bayer Crop Science seeks shareholder approval for Ravi Kirpalani as independent director
- Five-year term effective September 1, 2026, ending August 31, 2031
- Postal ballot voting runs from September 14 to October 13, 2026
- Cut-off date for eligibility is September 7, 2026

*this image is generated using AI for illustrative purposes only.
Bayer Crop Science has initiated a postal ballot process to seek shareholder approval for the appointment of Mr. Ravi Moti Kirpalani as a Non-Executive Independent Director. The Board approved the appointment effective September 1, 2026, subject to member consent via special resolution.
The five-year term runs until August 31, 2031. Shareholders whose names appear in the Register of Members or List of Beneficial Owners as on the cut-off date of September 7, 2026, are eligible to vote. The company appointed CS S. N. Viswanathan of M/s. S. N. Ananthasubramanian & Co. as the scrutinizer to oversee the voting process.
Voting Schedule
The remote e-voting period begins on Monday, September 14, 2026, at 9:00 am and concludes on Tuesday, October 13, 2026, at 5:00 pm. The resolution will be deemed passed on the same day as the voting end date. The scrutinizer is scheduled to submit the report on Thursday, October 15, 2026.
| Event | Date |
|---|---|
| Cut-off Date | Monday, September 07, 2026 |
| Dispatch Completion | Friday, September 11, 2026 |
| E-Voting Start | Monday, September 14, 2026 |
| E-Voting End | Tuesday, October 13, 2026 |
| Scrutinizer Report | Thursday, October 15, 2026 |
Governance Details
Mr. Kirpalani holds DIN 02613688. The Board previously intimated this proposal in a letter dated August 5, 2026. Bharati Shetty, Company Secretary & Compliance Officer, signed the intimation letter sent to BSE Limited on September 8, 2026.
Historical Stock Returns for Bayer Crop Science
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.04% | +0.45% | -4.51% | -13.31% | -21.52% | -26.16% |
How is Mr. Kirpalani's appointment expected to influence Bayer Crop Science's strategic direction in the Indian agri-chemical market over the next five years?
What specific expertise or industry experience does Mr. Kirpalani bring that addresses current governance gaps or regulatory challenges for the company?
How might this leadership change impact investor confidence and the stock's valuation leading up to the voting period in late 2026?


































